Revenue · 2013–2025

Iovance Biotherapeutics revenue

$264M+60.6% · FY2025

Iovance Biotherapeutics (IOVA) reported $264M in revenue for fiscal 2025, +60.6% year on year.

$02013$02014$02015$02016$02017$02018$1.2M2023$164M2024$264M2025
Iovance Biotherapeutics — Revenue, 2013–2025
Fiscal yearRevenueChangeFiling
FY20252025-12-31$264M+60.6%Open →
FY20242024-12-31$164M+13,699.0%Open →
FY20232023-12-31$1.2M+$1.2MOpen →
FY20182018-12-31$0$0Open →
FY20172017-12-31$0$0Open →
FY20162016-12-31$0$0Open →
FY20152015-12-31$0$0Open →
FY20142014-12-31$0$0Open →
FY20132013-12-31$0—Open →

Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Revenue at companies of similar size

Full ranking by revenue →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Iovance Biotherapeutics revenue |url=https://companiesranked.com/en/company/iovance-biotherapeutics/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Iovance Biotherapeutics revenue. CompaniesRanked. https://companiesranked.com/en/company/iovance-biotherapeutics/revenue

BibTeX

@misc{companiesranked-en-company-iovance-biotherapeutics-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Iovance Biotherapeutics revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/iovance-biotherapeutics/revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001104659-26-018899 · February 24, 2026

{{cite web |title=Iovance Biotherapeutics revenue — 10-K (0001104659-26-018899) |url=https://www.sec.gov/Archives/edgar/data/1425205/000110465926018899/iova-20251231x10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Iovance Biotherapeutics overview